Projects per year
Dr Varinder Jeet is a Research Fellow at the Macquarie University Centre for the Health Economy (MUCHE). Prior to joining MUCHE, Dr Jeet was a Postdoctoral Research Fellow at the Australian Prostate Cancer Research Centre, Queensland University of Technology (QUT) from 2010 to 2018 and a Research Officer at Mater Medical Research Institute, Brisbane from 2009-2010.
Varinder’s expertise lies in clinical/medical and health economics research. During his research career, Varinder has contributed to numerous research projects focussing on diagnosis, prognosis, and therapy. He generated and analysed data for two phase-1 prostate cancer clinical trials and discovered new mechanisms of cancer resistance and novel therapeutic approaches for advanced stages of cancer. He also discovered innovative techniques and biomarker panels for detecting cancer both at early and late stages of disease progression. As part of the high performing team at MUCHE, Varinder is currently contributing to Health Technology Assessments of new medicines and medical technologies.
Varinder’s research has featured in high-quality scholarly periodicals such as Journal of Experimental Medicine, Clinical Chemistry, Scientific Reports, Cancer and Metastasis Reviews, Endocrine-Related Cancer, and others. He has successfully supervised two PhD students, delivered lectures to university students, and acted as a reviewer for peer-reviewed journals and NHMRC project grants. As a member of the Australian Society for Medical Research (ASMR) organising committee, Varinder helped in organising the ASMR conference annual dinner 2016. He has also served on career counselling, conference organisation and OH&S committees. In addition, Varinder has been the recipient of prestigious research grants, travel grants and other awards.
Varinder has recently completed the Master of Health Economics degree to bridge the gap between clinical research and Health Technology Assessment (HTA). His broad knowledge of medical research areas and a solid educational background help him to understand the intricate processes of disease pathophysiology and ways to implement that knowledge in HTA procedures. Varinder is interested in economic modelling for therapeutic interventions, genetic testing/clinical genomics, cancer studies, and equity and public policy research.
Health Economics, Master of Health Economics, The University of Queensland
Award Date: 15 Jul 2019
Cancer Medicine, PhD in Medicine, The University of New South Wales
Award Date: 1 Dec 2009
Award Date: 1 Oct 2003
Biomedical Sciences, BSc
Award Date: 1 Jul 2001
Research Fellow, Queensland University of Technology2010 → 2018
Research Officer, Mater Medical Research Institute (MMRI)2009 → 2010
23/03/20 → 30/04/23
Services for external evaluation of Pharmaceutical Benefits Advisory Committee (PBAC) and health technology related submissions
1/11/16 → …
Novel prostate cancer target for diagnosis, imaging, detection of recurrence and response to therapy
3/08/15 → 1/08/18
Jeet, V. & Nelson, C.
20/09/09 → 20/05/17
Genetic testing for inherited kidney disease (other than Alport syndrome). Department Commissioned Assessment ReportNorman, A., Jeet, V., Hoyle, M., Song, R., Seil, E., Tirrell, Z., Sharma, R., Ahumada-Canale, A., Parkinson, B. & Cutler, H., 2020, Australian Government Department of Health. 425 p.
Research output: Book/Report › Commissioned report
Micro-costing study of Prostate Specific Membrane Antigen (PSMA) Positron emission tomography/Computed tomography (PET/CT). A report for Cyclotek for inclusion in a submission to the MSACSharma, R., Parkinson, B., Jeet, V., Song, R. & Hoyle, M., 2020, North Ryde, NSW: Macquarie University, Centre for the Health Economy. 8 p.
Research output: Book/Report › Commissioned report
Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)Yeh, M. C., Tse, B. W. C., Fletcher, N. L., Houston, Z. H., Lund, M., Volpert, M., Stewart, C., Sokolowski, K. A., Jeet, V., Thurecht, K. J., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., 7 May 2020, In: EJNMMI Research. 10, 13 p., 46.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile2 Citations (Scopus)4 Downloads (Pure)
Jeet, V., Clements, J. A., Gunter, J. H. & Batra, J., 1 Sep 2019, In: Clinical Chemistry. 65, 9, p. 1090-1101 12 p.
Research output: Contribution to journal › Review article › peer-review
Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathwayMoniruzzaman, M., Wang, R., Jeet, V., McGuckin, M. A. & Hasnain, S. Z., 15 Jul 2019, In: International Journal of Molecular Sciences. 20, 14, p. 1-17 17 p., 3468.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile11 Citations (Scopus)8 Downloads (Pure)
Varinder Jeet (Speaker)2008 → …
Activity: Talk or presentation › Invited talk
Varinder Jeet (Participant)
Impact: Quality of life impacts
Improving health and spending money wisely: evaluating medicines and vaccines for the Australian Government
Henry Cutler (Participant), Bonny Parkinson (Participant), Martin Hoyle (Participant), Mutsa Gumbie (Participant), Rachel Song (Participant), Andrew Partington (Participant), Varinder Jeet (Participant), Elizabeth Seil (Participant), Alicia Norman (Participant), Virginia Mumford (Participant), Sanjyot Vagholkar (Participant), Lisa Pont (Participant) & Janaki Amin (Participant)
Impact: Quality of life impacts, Economy impacts, Policy impacts